UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED

Universal Health International Group Holding Limited

2211

KYG9302L1106

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
0.045 ^HKD	+7.14%		-2.17%	-54.55%

Feb. 28	Universal Health International Group's Fiscal H1 Loss Narrows	MT
Feb. 27	Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Universal Health International Group Appoints Zuo Haiyan as Independent Non-Executive Director

July 21, 2017 at 10:14 am EDT

Universal Health International Group has appointed Zuo Haiyan as Independent Non-Executive Director. The effective date is July 20, 2017.

Latest news about Universal Health International Group Holding Limited

Universal Health International Group's Fiscal H1 Loss Narrows	Feb. 28	MT
Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27	CI
Universal Health International to Vote Jan. 30 on Sale of Pharmaceutical Wholesaler	Jan. 15	MT
Universal Health International Unit to Dispose of Pharmaceutical Wholesaler	Nov. 06	MT
Universal Health International Group Holding Limited Announces Company Secretary Changes	23-09-28	CI
Universal Health International Group Holding Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-27	CI
Universal Health International to Raise HK$13.4 Million with Share Subscription	23-03-27	MT
Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-24	CI
Universal Health International Chief Capital Operational Officer Steps Down	23-01-19	MT
Universal Health International Group Holding Limited Announces Executive Changes	23-01-19	CI
Universal Health International Chairman Resigns	22-12-12	MT
Universal Health International Group Holding Limited Announces Board Changes	22-12-12	CI
Universal Health International Group Holding Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-27	CI
Universal Health International Group Holding Limited Announces Appointment of Qiu Shuai as Chief Capital Operational Officer	22-05-20	CI
Universal Health International's Fiscal H1 Loss Narrows on Lower Expenses	22-02-25	MT
Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-24	CI
Universal Health International Group Holding Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-09-28	CI
Universal Health International : Projects $104 Million Loss in FY21; Shares Drop 3%	21-09-16	MT
Universal Health International Group Holding Limited Provides Group Earnings Guidance for the Year Ended June 30, 2021	21-09-15	CI
Universal Health International Group Holding Limited Announces Management Changes, with Effect from 1 August 2021	21-07-30	CI
Universal Health International Group Holding Limited Announces Executive Changes	21-07-30	CI
Universal Health International : Posts Wider Loss in July-December 2020	21-02-25	MT
Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-24	CI
Universal Health International Group Holding Limited Provides Earnings Guidance for the Six Months ended 31 December 2020	21-02-08	CI
Universal Health International Group Holding Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-09-24	CI

Chart Universal Health International Group Holding Limited

Duration

Period

Chart Universal Health International Group Holding Limited

More charts

Universal Health International Group Holding Limited is an investment holding company principally engaged in the distribution and retail of drugs and other pharmaceutical products in the northeastern region of the Peopleâs Republic of China (the PRC). The Company operates its business through four segments: Distributions, Retails I, Retails II and Others. The Others segment is engaged in investment business. Through its subsidiaries, the Company is also engaged in e-commerce and trading of health-care products.

Sector

Pharmaceuticals

Calendar

2024-09-25 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED	-54.55%	3.58M
MCKESSON CORPORATION	+17.35%	70.95B
SINOPHARM GROUP CO. LTD.	+5.38%	8.67B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.16B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.51B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-3.38%	4.07B
GALENICA AG	-2.61%	3.84B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+22.08%	3.63B